Discontinued — last reported Q3 '24
Business Segments · Amortization
Health & Science Technologies — Amortization
IDEX Health & Science Technologies — Amortization increased by 18.0% to $19.7M in Q3 2024 compared to the prior quarter.
Analysis
StatementSegment
CategoryProfitability
SignalContext dependent
VolatilityStable
First reportedQ3 2023
Last reportedQ3 2024Oct 30, 2024
Rolls up toAdjustment for Amortization
How to read this metric
Higher amortization reflects a larger base of acquired intangible assets, often signaling recent M&A activity and potential future cash flow generation.
Detailed definition
The systematic allocation of the cost of intangible assets, such as patents, customer relationships, and trademarks, ove...
Peer comparison
Standard across industrial and life science sectors; peers with high M&A growth typically show higher amortization levels.
Metric ID:
iex_segment_health_science_technologies_amortizationHistorical Data
2 periods
| Q3 '23 | Q3 '24 | |
|---|---|---|
| Value | $16.7M | $19.7M |
| QoQ Change | — | +18.0% |
| YoY Change | — | +18.0% |
Range$16.7M – $19.7M
Avg YoY Growth+18.0%
Median YoY Growth+18.0%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is IDEX's health & science technologies — amortization?
- IDEX (IEX) reported health & science technologies — amortization of $19.7M in Q3 2024.
- What does health & science technologies — amortization mean?
- The periodic expense recorded to account for the gradual loss of value of intangible assets over time.